Neumora
The SEC Reporting and Accounting Manager at Neumora Therapeutics supports the company's financial reporting process, oversees the monthly close for R&D activities, and ensures strong internal controls and SOX compliance. The role collaborates cross‑functionally with FP&A, Legal, HR, and Clinical Operations to provide accurate financial statements and SEC filings.
Headquarters
Watertown, Massachusetts, United States
Company Size
51-200 employees
Founded
2020
Neumora Therapeutics is a neuroscience-focused biopharmaceutical company pioneering a new era of precision medicines to restore brain health and wellbeing. The company develops targeted therapies for neurological and neuropsychiatric disorders by integrating human brain biology, genetics, biomarkers, and translational clinical models to improve patient selection and outcomes. Neumora partners with academic and industry collaborators to advance a pipeline of precision neurotherapeutics designed to address unmet needs in brain disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Neumora.
38% above the average for this role
Mizuho reiterates Outperform rating on Neumora Therapeutics stock
Jan 7, 2026
Director of Accounting & SEC Reporting
P.F. Chang's China Bistro, Inc.
Senior Accountant – SEC Reporting & Compliance
Monte Rosa Therapeutics, Inc
Staff Accountant
hirepoint recruiting
Sr. Accountant, Consolidation and SEC Reporting
Sunbelt Rentals
Accounting Manager
Porch Group
SEC and Financial Reporting Senior Manager
SI-BONE, Inc